Skip to content

MEDSCIENCE

Active
Private limited companyfounded 1999active for 27 yearsKroonstraat(LUB) 17, 3210 Lubbeek, BelgiumKBO/BCE: BE 0466.998.085

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-01-2027
2025
19-11
NBB filing Annual accounts 2025 filedPDF
abbreviated format · 73 days before the deadline
2024
17-12
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 45 days before the deadline
30-06
Financial Liquidity more than doubledcurrent ratio 51.36
The current ratio rises from 17.44 to 51.36. Short-term debt falls from €49,134 to €18,138.
10-01
Gazette deed Change of role: STEVENS Marleen, from manager to director
Legal-form conversion · Capital conversion · Reserve release10 points ▸
  • General meeting, 19-12-2023
  • Legal-form conversion, “Besloten vennootschap met beperkte aansprakelijkheid” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Reserve release, “opheffen, statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Purpose change
  • Amendment of the articles
  • Capital
  • Director resignation, STEVENS Marleen (manager)
  • Director appointment, STEVENS Marleen (director (not named in the articles))
  • Registered office clause, “3210 Lubbeek, Kroonstraat 17” (deed in Dutch)

Open the act in the Belgian Official Gazette

2023
20-12
NBB filing Annual accounts 2023 filedPDF
abbreviated format · 42 days before the deadline
30-06
Financial Highest result from 2019 to 2025net €145,602 ▲60.8%
The operating result of €217,822 and the net result of €145,602 are both a record.
2022
09-12
NBB filing Annual accounts 2022 filedPDF
abbreviated format · 53 days before the deadline
2021
17-12
NBB filing Annual accounts 2021 filedPDF
abbreviated format · 45 days before the deadline
2020
11-12
NBB filing Annual accounts 2020 filedPDF
abbreviated format · 51 days before the deadline
30-06
Financial Liquidity more than doubledcurrent ratio 40.87
The current ratio rises from 14.59 to 40.87. Short-term debt falls from €33,161 to €12,386.
30-06
Financial Equity above €500,000equity €539,618 ▲17.2%
With a profit in every financial year since 2019, equity grows to €539,618.
22-01
NBB filing Annual accounts 2019 filedPDF
abbreviated format · 9 days before the deadline
Show earlier events
2019
31-01
NBB filing Annual accounts 2018 filedPDF
abbreviated format · on the deadline day
2017
22-12
NBB filing Annual accounts 2017 filedPDF
abbreviated format · 40 days before the deadline
31-01
NBB filing Annual accounts 2016 filedPDF
abbreviated format · on the deadline day
1999
15-10
Gazette deed Incorporation
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

MEDSCIENCE was incorporated on 6 October 1999.1 STEVENS Marleen is director of the company, appointed in the act of 10-01-2024.2 Total assets rose from €494,222 in 2019 to €1.0m in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 10-01-2024
  3. 3National Bank, annual accounts 2019 and 2025

Next steps